Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Application of sanchi flower total saponine in preparing treatment hypertension disease medicament

A technology of hypertension and total saponins, applied in the field of application in the preparation of pharmaceutical compositions

Inactive Publication Date: 2008-06-18
LONGHUA HOSPITAL SHANGHAI UNIV OF TRADITIONAL CHINESE MEDICINE +1
View PDF2 Cites 4 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

There is no report on the treatment of hypertension

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of sanchi flower total saponine in preparing treatment hypertension disease medicament
  • Application of sanchi flower total saponine in preparing treatment hypertension disease medicament
  • Application of sanchi flower total saponine in preparing treatment hypertension disease medicament

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0012] Example 1 Extraction and Preparation of Panax notoginseng Saponins

[0013] Alcohol extraction, centrifugation, macroporous resin, concentration, drying and pulverization methods are used to obtain an extract of effective active ingredients of Panax notoginseng flower buds with stable transfer rate and yield and high purity. After color development by the vanillin-glacial acetic acid method, the ultraviolet spectrophotometry (UV) is detected at 548nm, and the weight percent content of the total saponins of the notoginseng flower buds in the extract accounts for 50%-100% of the total weight of the extract.

Embodiment 2

[0014] Example 2: Antihypertensive effect experiment of Panax notoginseng saponins on spontaneously hypertensive rats

[0015] 1. Select 18-week-old SHR rats and WKY rats (purchased from Shanghai Institute of Hypertension)

[0016] 2. Experimental grouping:

[0017] Normal WKY group (0.9% NS duodenum administration);

[0018] SHR rats were divided into blank group (0.9% NS duodenum administration);

[0019] Panax notoginseng total saponins low-dose group (0.8g / kg duodenum administration of Panax notoginseng total saponins);

[0020] The middle dose group of total saponins of Panax notoginseng flower buds (1.6g / kg duodenum administration of total saponins of Panax notoginseng flower buds);

[0021] Panax notoginseng total saponins high-dose group (3.2g / kg duodenum administration of Panax notoginseng total saponins);

[0022] Nifedin group (nifedin 5mg / kg duodenal administration).

[0023] 3. Acute antihypertensive test:

[0024] Each group was anesthetized with 2% sodium ...

Embodiment 3

[0029] Example 3: Effect test of Panax notoginseng saponins on the proliferation of vascular smooth muscle cells

[0030] Human primary aortic smooth muscle cell line (HASMC) was selected, and the concentration of ET-1 was 2*10 -8 Mmol / L pretreatment of HASMC caused the abnormal proliferation of HASMC, observed different concentrations of Panax notoginseng saponins (50, 100, 150, 200, 250, 300, 350, 400, 450, 500, 550, 600 μg / ml) and control Drug nifedipine (50μg / ml) on it. The results showed that Panax notoginseng saponins could improve the cell viability of ET-1-induced vascular smooth muscle cell proliferation (see figure 1 , figure 2 ).

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention belongs to the field of Chinese medicine pharmacy, which relates to the application of pseudo-ginseng flower total saponin of active energy for preparing the drug for the treatment of hypertension, and the pseudo-ginseng flower total saponin is extracted from Chinese herbal medicine pseudo-ginseng flower. The in-vitro and in-vivo animal experimental results for the active energy of the invention show that the active energy can significantly lower blood pressure of spontaneously hypertensive rats (SHR), and improve the cell activity of vascular smooth muscle cell proliferation which is induced by ET-1, as well as increase the apoptosis rate of the vascular smooth muscle cell and the NO content inside the vascular smooth muscle cell; simultaneously the active energy can promote the expression of iNOS, and reduce Ca2 + concentration inside the vascular smooth muscle cell, as well as inhibite the oncogene c-mycmRNA expression of the vascular smooth muscle cell; thereby the pseudo-ginseng flower total saponin can be taken as raw material for preparing pharmaceutical preparation for the prevention of hypertension.

Description

technical field [0001] The invention belongs to the field of traditional Chinese medicine pharmacy, and relates to the application of total saponins of Panax notoginseng, the active part extracted from the Chinese herbal medicine Panax notoginseng, in the preparation of pharmaceutical compositions. Background technique [0002] Hypertension is one of the common cardiovascular diseases. According to statistics, the current incidence rate in my country is 13.58%. It is closely related to coronary atherosclerotic heart disease and cerebrovascular diseases. Although modern medicine has made great progress, But it is still one of the leading causes of death from cardiovascular disease. In recent years, with the progress of large-scale antihypertensive clinical trials and basic research on cardiovascular molecular biology, people have gradually realized that hypertension is not only a disease of hemodynamic abnormalities, but also the accumulation of various cardiovascular risk fac...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/258A61P9/12A61K31/704
Inventor 周端魏莉胡林森苑素云杜奕刘岭周浩
Owner LONGHUA HOSPITAL SHANGHAI UNIV OF TRADITIONAL CHINESE MEDICINE
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com